Med-IQ (@MedIQCME) header
Med-IQ (@MedIQCME) profile picture

We empower people at every level of the healthcare delivery system with the knowledge needed to continuously improve provider performance and patient outcomes.

Baltimore, MD
Joined September 2009
Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)Photo by Med-IQ (@MedIQCME)
Who should undergo lung cancer screening, and how often? Review current guideline recommendations and considerations for annual screening with eligible patients in this brief CME activity for primary care clinicians. Access the Course: clinical.med-iq.com/activity…
1
21
The ATTR-CM treatment landscape is evolving. Are you prepared to integrate emerging therapies into patient care? Review key treatment updates presented at HFSA 2025 and AHA 2025 and explore practical strategies for incorporating new and emerging therapies into ATTR-CM management in this complimentary CME activity: clinical.med-iq.com/activity…
1
26
Managing relapsed/refractory multiple myeloma requires balancing emerging treatment options with real-world patient needs. This complimentary CME series explores BCMA-directed therapies, treatment selection, access considerations, and strategies to support individualized care. Access the series: clinical.med-iq.com/series/a…
30
Novel factor XI/XIa inhibitors are being investigated as a potential strategy for reducing stroke risk in patients with atrial fibrillation. Stay current with the latest evidence and explore how these investigational agents compare with currently available anticoagulants in this complimentary CME activity: clinical.med-iq.com/activity…
23
Live from #ScientificSessions26! Keep up with the latest developments in ATTR-CM with @MasriAhmadMD, sharing key data and expert insights throughout the meeting. #MedIQScientificSessions26
1
1
107
In this CME activity, Dillon Cockrell, MD, highlights how ¹⁷⁷Lu-PSMA-617 is reshaping treatment for patients with metastatic castration-resistant prostate cancer. Earn CME: clinical.med-iq.com/activity…
29
Join our live session on 11/18 at 5 pm ET to hear a discussion on new clinical data for IDH1 inhibitors, including current and investigational uses in newly diagnosed and relapsed/refractory AML and the integration of emerging data into treatment decisions. xitter.gq/i/broadcasts/2WXEKBooK…
24
#TLM26 has started! Don't miss @ebtapper posting live updates on emerging therapies and functional cure strategies for hepatitis B from the meeting. #MedIQTLM26 #HepatitisB #HBV
1
1
326
In this case-based CME activity, Amanda Hayes, MD, highlights how to recognize when progressive symptoms, despite conservative care, signal the need for orthopaedic referral. Review the case: clinical.med-iq.com/activity…
1
26
Catch up on the latest ATTR-CM advances presented at ACC 2026 with Sarah Cuddy, MBBCh, and Prem Soman, MD, PhD. The discussion reviews new clinical trial data and practical considerations for integrating emerging evidence into treatment and management considerations. Access the podcast: acc.org/Latest-in-Cardiology…
1
31
New data in R/M HNSCC shows varying activity across PI3K, CD47, TIGIT, LAG-3/TIM-3, and EGFR‑targeting strategies. Review the evidence & earn CME: clinical.med-iq.com/activity…
39
In this CME/CE activity, faculty examine the timely identification of AF and review contemporary rhythm-control considerations, including wearable devices, antiarrhythmic drugs, catheter ablation, and patient-centered decision making. Access the activity: clinical.med-iq.com/activity…
26
In this case-based CME activity, Amy Behman, MBChB, PhD, FRCSC, explores how persistent symptoms can signal underlying hip dysplasia and the need for orthopaedic referral. Review the case: clinical.med-iq.com/activity…
27
When CKD is part of the picture, how should hypertension and CVD management be approached? Join this complimentary, live ECHO session to explore cardiovascular risk management and integrated care strategies: bostonu.zoom.us/meeting/regi…
39
What's standing in the way of diagnosis? Explore diagnosis, treatment information related to mavacamten and aficamten, and approaches to keeping patients informed about living with HCM in this CME activity. Check your answer: clinical.med-iq.com/activity…
43
#RiskTipTuesday: Is your EHR strengthening team communication? - Support efficient communication - Document calls + nontraditional encounters - Provide ongoing training for all users Stronger communication = safer care + reduced risk. #RiskTipTuesday #PatientSafety #RiskManagement
23
Bridging evidence and practice in ATTR-CM. In this complimentary CME activity, Ahmad Masri, MD, MS, reviews key clinical trial data and explores how these new findings can be applied to patient scenarios representative of contemporary clinical practice. Access the CME: clinical.med-iq.com/activity…
38
Increases in the number of maternal care deserts have left many EDs to serve as safety nets for OB emergencies. Register for our complimentary live webinar on 11/5, 12 pm ET to review factors in the maternal care crisis and practical approaches to improve obstetric care: med-iq.zoom.us/webinar/regis…
26